Cargando…
Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial
BACKGROUND: Trimetazidine (TMZ) pretreatment protects cardiomyocytes during cardiac surgery. TMZ may protect elderly patients with ischaemic heart disease (IHD) undergoing non-cardiac surgery. METHODS: This was a randomized, double-blind, placebo-controlled trial (registration #ChiCTR1900025018) of...
Autores principales: | Dai, Zhong-Liang, Song, Yi-Feng, Tian, Ya, Li, Yin, Lin, Miao, Lin, Juan, Wang, Qi, Wang, Ping, Gao, Wen-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485575/ https://www.ncbi.nlm.nih.gov/pubmed/34598676 http://dx.doi.org/10.1186/s12872-021-02287-w |
Ejemplares similares
-
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study
por: Rosano, Giuseppe MC, et al.
Publicado: (2003) -
Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Tang, Xiuying, et al.
Publicado: (2022) -
Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
por: Shao, Shuai, et al.
Publicado: (2019) -
Effect of trimetazidine on heart rate variability in elderly patients with acute coronary syndrome
por: Zhang, Jing, et al.
Publicado: (2016) -
Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
por: Zhang, Ying, et al.
Publicado: (2015)